Keyphrases
Screening Method
100%
Neurodegenerative Diseases
100%
Neurodegeneration
100%
Drug Screening
100%
Easy-to-implement
100%
Alpha-synuclein (α-syn)
100%
Chemical Library
100%
High-throughput Screening
100%
Parkinson's Disease
100%
Therapeutic Strategies
100%
High-throughput
100%
Recombinant Protein
100%
Low Protein
100%
Incubation
100%
High Reproducibility
100%
Plate Method
100%
Aggregated Protein
100%
In Vitro Aggregation
100%
Intraneuronal
100%
Amyloid Aggregates
100%
α-Synuclein Aggregation Inhibitor
100%
Disease-modifying Agents
100%
Aggregation Modulator
100%
Protein Quantity
100%
Anti-aggregation
100%
Aggregation Inhibitor
100%
Aggregation Assay
100%
Aggregation Kinetics
100%
Medicine and Dentistry
In Vitro
100%
High Throughput Screening
100%
Alpha Synuclein
100%
Diseases
50%
Drug Screening
50%
Neurodegeneration
50%
Degenerative Disease
50%
Parkinson's Disease
50%
Reproducibility
50%
Incubation
50%
Amyloid Protein
50%
Recombinant Protein
50%
Pharmacology, Toxicology and Pharmaceutical Science
High-Throughput Screening
100%
Alpha Synuclein
100%
Drug Screening
50%
Disease
50%
Degenerative Disease
50%
Nerve Degeneration
50%
Parkinson's Disease
50%
Recombinant Protein
50%
Amyloid Protein
50%
Neuroscience
Alpha-Synuclein
100%
In Vitro
100%
Parkinson's Disease
50%
Neurodegenerative Disorder
50%
Neurodegeneration
50%
Recombinant Protein
50%
Amyloid Protein
50%
Biochemistry, Genetics and Molecular Biology
High Throughput Screening
100%
Alpha-Synuclein
100%
Recombinant Protein
50%
Drug Screening
50%
Amyloid Protein
50%